- Home
- CYBN vs CCII Comparison
CYBN vs CCII Comparison
Compare CYBN & CCII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CYBN | CCII |
|---|---|---|
| Founded | 2019 | 2024 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.9M | 355.3M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | CYBN | CCII |
|---|---|---|
| Price | $6.62 | $10.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $74.50 | N/A |
| AVG Volume (30 Days) | ★ 626.1K | 58.8K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.81 | $10.07 |
| 52 Week High | $10.73 | $10.47 |
Technical Indicators
Market Signals| Indicator | CYBN | CCII |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | N/A |
| Support Level | $5.70 | N/A |
| Resistance Level | $6.20 | N/A |
| Average True Range (ATR) | 0.35 | 0.00 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 85.82 | 0.00 |
Price Performance
Historical ComparisonAbout CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About CCII Cohen Circle Acquisition Corp. II Class A Ordinary Shares
Cohen Circle Acquisition Corp II is a blank check company.